Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib.

Saved in:
Bibliographic Details
Title: Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib.
Authors: Kawano M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Kunimoto H; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. kunimoto@yokohama-cu.ac.jp., Izumi A; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan., Adachi A; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Miura A; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Yokoyama C; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Hasegawa K; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan., Shirafuta M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Tanaka M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Sakuma T; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Ohashi T; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Takahashi H; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan., Miyazaki T; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan., Tachibana T; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Hagihara M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Matsumoto K; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan., Nakajima H; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Source: Annals of hematology [Ann Hematol] 2026 Feb 23; Vol. 105 (4). Date of Electronic Publication: 2026 Feb 23.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41729290
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kawano+M%22">Kawano M</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Kunimoto+H%22">Kunimoto H</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. kunimoto@yokohama-cu.ac.jp.<br /><searchLink fieldCode="AU" term="%22Izumi+A%22">Izumi A</searchLink>; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Adachi+A%22">Adachi A</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Miura+A%22">Miura A</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Yokoyama+C%22">Yokoyama C</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Hasegawa+K%22">Hasegawa K</searchLink>; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Shirafuta+M%22">Shirafuta M</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+M%22">Tanaka M</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Sakuma+T%22">Sakuma T</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Ohashi+T%22">Ohashi T</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+H%22">Takahashi H</searchLink>; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Miyazaki+T%22">Miyazaki T</searchLink>; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Tachibana+T%22">Tachibana T</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Hagihara+M%22">Hagihara M</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Matsumoto+K%22">Matsumoto K</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.<br /><searchLink fieldCode="AU" term="%22Nakajima+H%22">Nakajima H</searchLink>; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Feb 23; Vol. 105 (4). <i>Date of Electronic Publication: </i>2026 Feb 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41729290
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00277-026-06896-3
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Successful treatment of relapsed FLT3-mutated donor cell-derived MDS/AML with FLT3 inhibitor gilteritinib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kawano M
      – PersonEntity:
          Name:
            NameFull: Kunimoto H
      – PersonEntity:
          Name:
            NameFull: Izumi A
      – PersonEntity:
          Name:
            NameFull: Adachi A
      – PersonEntity:
          Name:
            NameFull: Miura A
      – PersonEntity:
          Name:
            NameFull: Yokoyama C
      – PersonEntity:
          Name:
            NameFull: Hasegawa K
      – PersonEntity:
          Name:
            NameFull: Shirafuta M
      – PersonEntity:
          Name:
            NameFull: Tanaka M
      – PersonEntity:
          Name:
            NameFull: Sakuma T
      – PersonEntity:
          Name:
            NameFull: Ohashi T
      – PersonEntity:
          Name:
            NameFull: Takahashi H
      – PersonEntity:
          Name:
            NameFull: Miyazaki T
      – PersonEntity:
          Name:
            NameFull: Tachibana T
      – PersonEntity:
          Name:
            NameFull: Hagihara M
      – PersonEntity:
          Name:
            NameFull: Matsumoto K
      – PersonEntity:
          Name:
            NameFull: Nakajima H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 02
              Text: 2026 Feb 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0584
          Numbering:
            – Type: volume
              Value: 105
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Annals of hematology
              Type: main
ResultId 1